"My relationship with uBiome now offers me a greater platform from which to educate others on the need to care for and properly test the specific gut and vaginal microbiomes." Dr. Felice Gersh
SAN FRANCISCO (PRWEB) May 03, 2018
uBiome, the leading company in microbial genomics, announces the addition of obstetrics and gynecology expert, Dr. Felice Gersh, to its prolific board of advisors. With extensive experience in the fields of obstetrics, gynecology, and internal medicine, Dr. Gersh brings to the board a unique perspective on women's healthcare.
About joining uBiome's expert board, Dr. Gersh said: “When I was approached with the invitation to join the Scientific Advisory Board for uBiome, I was thrilled! My relationship with uBiome now offers me a greater platform from which to educate others on the need to care for and properly test the specific gut and vaginal microbiomes. I look forward to growing my personal appreciation and knowledge of human and microbial life. I also anticipate expanding my knowledge on the best ways to optimize human health through the testing and nurturing of our microbiomes by harnessing this brand new understanding we have of what it means to be human.”
The Director of the Integrative Medical Group of Irvine, Dr. Gersh holds a medical degree from the USC School of Medicine, where she was named the top female graduating physician and was in the top five percent of her class. A renowned specialist on the subject of women’s health, Dr. Gersh has lectured at medical conferences around the world and is due to publish a book on Polycystic Ovary Syndrome. She has received the Orange County Medical Association's Physician of the Year Award for the last 13 years, as well as Southern California's “Super Doctor” award. To date, her OB/GYN and Integrative Medicine practice is the most successful in the Irvine, California area. To read more about Dr. Gersh, or to follow her blog, visit http://www.felicelgershmd.com/
“We are delighted to welcome Dr. Gersh to our Scientific Advisory Board,” said Dr. Jessica Richman, PhD, co-founder and CEO of uBiome. “Her knowledge in the field of obstetrics and gynecology, combined with her experience as a fellowship-trained integrative medicine expert, will greatly benefit uBiome's mission as we continue to develop the science of the vaginal microbiome in revolutionary products like our SmartJane™ test.”
SmartJane is the first sequencing-based, doctor-ordered, at-home women’s health test to combine human papillomavirus (HPV) genotyping, sexually transmitted infections (STI) testing, and microbial risk factors for HPV infection, as well as bacterial vaginosis, cervicitis, idiopathic infertility, pelvic inflammatory disease, bacterial vaginosis, and aerobic vaginitis. The test is not intended to replace traditional Pap smears or well woman visits. Like all uBiome tests, SmartJane has an easy sample collection process that takes under two minutes to complete and is mailed directly to the laboratory, making it simple and convenient to use. Interested individuals can request a test through their healthcare provider or learn more by visiting https://ubiome.com/clinical/smartjane/
Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to transform the science of the microbiome into reliable, accurate products and services that improve people’s lives. uBiome is funded by Y Combinator, Andreessen Horowitz, and 8VC, as well as other leading investors. The company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018.